SpineGuard SA (EPA:ALSGD)
France · Delayed Price · Currency is EUR 0.1016
-0.0004 (-0.39%)
May 11, 2026, 5:11 PM CET
SpineGuard Revenue
In the year 2025, SpineGuard had annual revenue of 3.76M EUR, down -19.16%. SpineGuard had revenue of 1.64M in the half year ending December 31, 2025, a decrease of -21.25%.
Revenue
3.76M
Revenue Growth
-19.16%
P/S Ratio
2.54
Revenue / Employee
289.02K
Employees
13
Market Cap
9.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.76M | -890.77K | -19.16% |
| Dec 31, 2024 | 4.65M | 335.24K | 7.77% |
| Dec 31, 2023 | 4.31M | -1.29M | -22.98% |
| Dec 31, 2022 | 5.60M | 1.19M | 27.11% |
| Dec 31, 2021 | 4.41M | -446.53K | -9.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Biosynex | 115.13M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Bluelinea Société Anonyme | 11.69M |
| Mauna Kea Technologies | 8.91M |